Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.31−0.03 (-8.29%)
Close on Nov 18, 2026Market cap $2.51MP/E –Yield –
Q/C Technologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Q/C Technologies's revenue for the twelve months ending Jun 30, 2020 was $862.02K, down 54.9% year over year. For fiscal 2019 it was $1.58M, down 5.3% from the year before. The highest annual figure on record is $4.43M in fiscal 2014.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $1.58M | -5.3% |
| FY2018 | Dec 31, 2018 | $1.67M | -50.4% |
| FY2017 | Dec 31, 2017 | $3.35M | +13.3% |
| FY2016 | Dec 31, 2016 | $2.96M | +40.0% |
| FY2015 | Dec 31, 2015 | $2.12M | -52.2% |
| FY2014 | Dec 31, 2014 | $4.43M | +23.7% |
| FY2013 | Dec 31, 2013 | $3.58M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | -$1.89K | -100.4% |
| Q1 FY2020 | Mar 31, 2020 | $363.52K | -40.6% |
| Q4 FY2019 | Dec 31, 2019 | $79.59K | -71.5% |
| Q3 FY2019 | Sep 30, 2019 | $420.81K | -24.5% |
| Q2 FY2019 | Jun 30, 2019 | $464.51K | -11.8% |
| Q1 FY2019 | Mar 31, 2019 | $612.12K | +102.4% |
| Q4 FY2018 | Dec 31, 2018 | $279.41K | -74.0% |
| Q3 FY2018 | Sep 30, 2018 | $557.09K | -16.5% |
| Q2 FY2018 | Jun 30, 2018 | $526.60K | -19.4% |
| Q1 FY2018 | Mar 31, 2018 | $302.48K | -50.7% |
| Q2 FY2017 | Jun 30, 2017 | $1.07M | +12.2% |
| Q1 FY2017 | Mar 31, 2017 | $667.25K | -9.6% |
| Q4 FY2016 | Dec 31, 2016 | $653.20K | – |
| Q3 FY2016 | Sep 30, 2016 | $613.20K | – |
| Q2 FY2016 | Jun 30, 2016 | $956.49K | – |
| Q1 FY2016 | Mar 31, 2016 | $738.02K | – |
See a number that looks wrong?